Approval · Notice of Compliance 5453 · 1994
PARLODEL: Notice of Compliance 5453
Issued November 10, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5453
- Date
- November 10, 1994
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Prolactin inhibitor, growth hormone suppressant in acromegaly, adjunctive medication in parkinson's disease
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PARLODEL | Not yet assigned | — |
Medicinal ingredients
- BROMOCRIPTINE MESYLATE 2.5 MG per TAB
- BROMOCRIPTINE MESYLATE 5 MG per CAP